Concepedia

Author

Steve Qi

Ferring Pharmaceuticals (Switzerland)

Also Known As

Steve Qi

10

Publications

197

Citations

6

H-Index

10

Concepts

All Affiliations

Ferring Pharmaceuticals (Switzerland)
SQ

About

Steve Qi is an author at Ferring Pharmaceuticals (Switzerland) specializing in pharmacotherapy, drug discovery, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

70

2

Pharmacology

2

2

70

3

Biochemistry

1

1

36

4

Endocrinology

1

1

34

5

Immunology

1

1

36

Steve Qi

×

6

Publications

190

Citations

6

H-Index

YearCitations

Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome

Diane M. Hargrove, Sudarkodi Alagarsamy, Glenn Croston,

Journal of Pharmacology and Experimental Therapeutics

2020

56

Pharmacological Characterization of FE 202158, a Novel, Potent, Selective, and Short-Acting Peptidic Vasopressin V1a Receptor Full Agonist for the Treatment of Vasodilatory Hypotension

Régent Laporte, Arash Kohan, Joshua Heitzmann,

Journal of Pharmacology and Experimental Therapeutics

2011

38

Synthesis and Pharmacological Characterization of Novel Glucagon-like Peptide-2 (GLP-2) Analogues with Low Systemic Clearance

Kazimierz Wiśniewski, Javier Sueiras-Diaz, Guangcheng Jiang,

Journal of Medicinal Chemistry

2016

36

New, Potent, and Selective Peptidic Oxytocin Receptor Agonists

Kazimierz Wiśniewski, Sudarkodi Alagarsamy, Robert Galyean,

Journal of Medicinal Chemistry

2014

34

Unlike arginine vasopressin, the selective V1a receptor agonist FE 202158 does not cause procoagulant effects by releasing von Willebrand factor*

Sebastian Rehberg, Perenlei Enkhbaatar, Janina Rehberg,

Critical Care Medicine

2012

16

Discovery of Potent, Selective, and Short-Acting Peptidic V<sub>2</sub> Receptor Agonists

Kazimierz Wiśniewski, Steve Qi, John E. Kraus,

Journal of Medicinal Chemistry

2019

10

Page 1